Explanatory Note
Title: Research and development in biotechnology
It comprises experimental research and development (R&D) in biotechnology,
namely, about:
- DNA/RNA (genomics, pharmacogenomics, gene probes, genetic engineering,
DNA/RNA sequences/syntheses/amplifications, gene expression profile and use of
anti-messenger technology). DNA (Deoxyribonucleic Acid) consists of a molecule
complex biological structure that determines protein structure and encodes genetic information and
RNA (Ribonucleic Acid) allows DNA to carry out protein synthesis.
- Proteins and other molecules (sequences/synthesis/engineering of proteins and peptides,
large molecule hormones, improving delivery methods for large molecules
medication; proteomics, protein isolation and purification, signaling,
identification of cell receptors;
- Tissue culture, cells and engineering (cell/tissue culture, tissue engineering,
tissue “skeletons”, biomedical engineering, cell fusion, stimulants, vaccines/immune and
embryo manipulation);
- Biotechnological process techniques (fermentation using bioreactors, bioprocessing,
bioleaching, biodefibration, biodisplacement, biodesulfurization, biorecovery, biofiltration
and phytorecovery);
- RNA and gene vectors (gene therapy and viral vectors);
- Bioinformatics (construction of genome database, protein sequences,
complex modeling of biological processes and systems);
- Nanobiotechnology (applies nano-microfabrication tools and processes to build
devices to study biosystems and applications in drug delivery,
diagnostics and other applications.
Does not include:
DNA sequencing to exclude or cure a specific disease (86911);